Chemoinformaics analysis of balchanolide acetate
| Molecular Weight | 292.375 | nRot | 1 |
| Heavy Atom Molecular Weight | 268.183 | nRig | 16 |
| Exact Molecular Weight | 292.167 | nRing | 2 |
| Solubility: LogS | -2.652 | nHRing | 1 |
| Solubility: LogP | 3.37 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 47.601 |
| nHD | 0 | BPOL | 29.285 |
| QED | 0.55 |
| Synth | 4.563 |
| Natural Product Likeliness | 3.178 |
| NR-PPAR-gamma | 0.02 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.043 |
| Pgp-sub | 0.002 |
| HIA | 0.273 |
| CACO-2 | -4.528 |
| MDCK | 0.0000483 |
| BBB | 0.792 |
| PPB | 0.803969 |
| VDSS | 1.524 |
| FU | 0.147644 |
| CYP1A2-inh | 0.08 |
| CYP1A2-sub | 0.082 |
| CYP2c19-inh | 0.051 |
| CYP2c19-sub | 0.704 |
| CYP2c9-inh | 0.036 |
| CYP2c9-sub | 0.224 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.104 |
| CYP3a4-inh | 0.315 |
| CYP3a4-sub | 0.293 |
| CL | 2.514 |
| T12 | 0.155 |
| hERG | 0.005 |
| Ames | 0.102 |
| ROA | 0.121 |
| SkinSen | 0.081 |
| Carcinogencity | 0.125 |
| EI | 0.047 |
| Respiratory | 0.433 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.717847 |